New blood test can detect lung cancer before symptoms show up
BBC - 10-Sep-2019Detects 50% more early stage lung cancers and being expanded to detect other types
Join the club for FREE to access the whole archive and other member benefits.
Clinician, Mechanical Engineer and Chief Executive Officer at Oncimmune.
Dr. Adam M Hill MB PhD is a dual-qualified Clinician and Mechanical Engineer with a career built at the interface of industry, academia and health systems. Over the last 2 decades he has trained in surgery in the British Army; founded a successful applied research centre at Imperial College London; provided growth strategy and investment advice to global life science companies on behalf of the British Government; led the global medical function of a multinational, publicly-listed health IT company; and pivoted a Formula One team into a developer of health technology. Currently, Adam is a Visiting Professor in Global Health Innovation at Imperial College London, sits on the Value Creation Committee of Imperial College Health Partners and is Non Executive Director of Myrecovery.ai.
Visit website: https://oncimmune.com/board-of-directors/
See also: Oncimmune - Immunodiagnostic for detection and care of cancer.
Details last updated 08-Nov-2019
Detects 50% more early stage lung cancers and being expanded to detect other types